Showing results (161-170 of 167) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 167 results.
Carcinogenesis|June 3, 2000
Mutagen sensitivity and environmental exposures as contributing causes of chromosome 3p losses in head and neck cancersS P Schantz, Q Huang, K Shah, et al.Optics Letters|November 2, 2013
Simultaneous dual wavelength eye-tracked ultrahigh resolution retinal and choroidal optical coherence tomographyA Unterhuber, B Považay, A Müller, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 30, 2019
Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanomaY J L Jansen, E A Rozeman, R Mason, et al.European Journal of Cancer (Oxford, England : 1990)|December 25, 2024
An update on access to novel treatment for metastatic melanoma in Europe - A 2024 survey of the European melanoma registry and the European association of dermato-oncologyL Kandolf, P A Ascierto, L Bastholt, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2020
Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countriesL Kandolf-Sekulovic, K Peris, A Stratigos, et al.European Journal of Cancer (Oxford, England : 1990)|November 3, 2018
Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countriesL Kandolf Sekulovic, J Guo, S Agarwala, et al.European Journal of Cancer (Oxford, England : 1990)|March 8, 2017
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsL Kandolf Sekulovic, K Peris, A Hauschild, et al.Pageof 17